Prosecution Insights
Last updated: August 18, 2026
Application No. 18/570,018

NONANIC ACID ESTERS

Final Rejection §102
Filed
Dec 13, 2023
Priority
Jun 18, 2021 — EU 21180241.8 +1 more
Examiner
JONES-FOSTER, ERICA NICOLE
Art Unit
1656
Tech Center
1600 — Biotechnology & Organic Chemistry
Assignee
Evonik Operations GmbH
OA Round
2 (Final)
50%
Grant Probability
Moderate
3-4
OA Rounds
8m
Est. Remaining
98%
With Interview

Examiner Intelligence

Grants 50% of resolved cases
50%
Career Allowance Rate
38 granted / 76 resolved
-10.0% vs TC avg
Strong +48% interview lift
Without
With
+47.5%
Interview Lift
resolved cases with interview
Typical timeline
3y 4m
Avg Prosecution
56 currently pending
Career history
150
Total Applications
across all art units

Statute-Specific Performance

§101
8.2%
-31.8% vs TC avg
§103
38.7%
-1.3% vs TC avg
§102
20.4%
-19.6% vs TC avg
§112
23.8%
-16.2% vs TC avg
Black line = Tech Center average estimate • Based on career data from 76 resolved cases

Office Action

§102
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claims 1-19 are pending. Claims 8-15 stands withdrawn pursuant to 37 CFR 1.142(b). Claims 1-7, 16-19 are pending and examined on the merits. Applicant’s remarks filed on 5/4/2026 in response to the Non-Final Rejection mailed on 2/5/2026 have been fully considered and are deemed persuasive to overcome at least one of the rejections and/or objections as previously applied. The text of those sections of Title 35 U.S. Code not included in the instant action can be found in the prior Office Action. Priority Acknowledgement is made of this national stage entry of PCT/EP2022/064529 of Non-provisional Application No. 18/570,018, filed on 5/30/2022, which claims foreign priority under 35 U.S.C. 119(a)-(d) to European Patent Application No. EP21180241.8, filing date 6/18/2021. The certified copy has been filed in the present application on 12/13/2023. It is noted, however, that applicant has not filed a certified copy of the English translation as required by 37 CFR 1.55. Information Disclosure Statement The information disclosure statement (IDS) submitted on 4/28/2026 is acknowledged. The submission is in compliance with the provisions of 37 CFR 1.97. Accordingly, the information disclosure statement has been considered by the examiner. Withdrawn Rejections The provisional rejection of claims 1-7, 16-19 on the grounds of nonstatutory double patenting as being unpatentable over claims 1, 4, 8, 10, 14 of U.S. Patent Application 18570395 is withdrawn in view of the instant application claimed mixture of n-nonanoic esters of xylitol, sorbitol being distinctly different from the art claimed anhydro sugar alcohol N-nonanoic acid ester. Maintained Claim Rejections - 35 USC § 102 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(2) the claimed invention was described in a patent issued under section 151, or in an application for patent published or deemed published under section 122(b), in which the patent or application, as the case may be, names another inventor and was effectively filed before the effective filing date of the claimed invention. The rejection of claims 1-7, 16-19 under 35 U.S.C. 102(a)(2) as being anticipated by ‘411 (WO 2020116411, Date of Filing: 2019-12-03, cited on IDS dated 12/13/2023) {herein ‘411} is maintained. Claims 1-4, 16-19 are drawn to a mixture of n-nonanoic esters of xylitol, sorbitol or erythritol, comprising: at least two of the esters which differ with regard to at least one esterification position of at least one nonanoyl radical in the xylitol, sorbitol or erythritol, with the proviso that n-nonanoic esters of erythritol with an average level of esterification of greater than 3.2 are excluded. Claims 5-7 are drawn to a mixed composition comprising the mixture of n- nonanoic esters according to Claim 1, wherein said composition comprises less than 25% by weight, of free n-nonanoic acid, where the percentages by weight are based on the sum total of all n- nonanoic esters of xylitol, sorbitol and erythritol and n-nonanoic acid. With respect to claim 1, ‘411 teaches a composition (composition B) comprising n-nonanoic acid, xylitol and sorbitol (pages 1, para 2; page 2, para 2; page 3, para 5). It is known by those of ordinary skill in the art that mixing a polyol with n-nonanoic acid produces polyol esters. As such, absent evidence otherwise, it is the Examiner’s position that a composition comprising n-nonanoic acid, xylitol and sorbitol would necessarily produce a mixture (composition) of n-nonanoic esters of xylitol and sorbitol. Since said composition does not include erythritol, it is the Examiner’s position that it would necessarily exclude n-nonanoic esters of erythritol with an average level of esterification of greater than 3.2. Additionally, absent evidence otherwise, it is the Examiner’s position that at least one esterification position of at least one nonanoyl radical in the xylitol and sorbitol would be different based on the chemical structures of the sugar alcohols. It is commonly known in the art that both xylitol (5 carbons with 5 hydroxyl groups) and sorbitol (6 carbon with 6 hydroxyl groups) possess different numbers of hydroxyl groups and carbon chain lengths, which leads to distinct regioselectivity. With respect to claim 2, since the art teaches the structure of a mixture of n-nonanoic esters of xylitol and sorbitol, it is the Examiners position that the composition would necessarily comprise at least two regioisomers of the mono-n- nonanoic ester. With respect to claim 3, since the art teaches the structure of a mixture of n-nonanoic esters of xylitol and sorbitol, it is the Examiners position that the composition would necessarily comprise mono-n-nonanoic ester and di-n- nonanoic ester. With respect to claim 4, since the art teaches the structure of a mixture of n-nonanoic esters of xylitol and sorbitol, it is the Examiners position that the composition would necessarily have an average level of esterification of 1.0 to 4.0. With respect to claim 5, ‘411 teaches a composition B comprising n-nonanoic acid, xylitol and sorbitol (pages 1, para 2; page 2, para 2; page 3, para 5). It is known by those of ordinary skill in the art that mixing polyol with n-nonanoic acid produces polyol esters. As such, absent evidence otherwise, it is the Examiner’s position that a composition comprising n-nonanoic acid, xylitol and sorbitol would necessarily produce s mixture of n-nonanoic esters of xylitol, sorbitol. Since said composition does not include erythritol, it is the Examiner’s position that it would necessarily exclude n-nonanoic esters of erythritol with an average level of esterification of greater than 3.2. Additionally, absent evidence otherwise, it is the Examiner’s position that at least one esterification position of at least one nonanoyl radical in the xylitol and sorbitol would be different based on the chemical structures of the sugar alcohols. It is commonly known in the art that both xylitol (5 carbons with 5 hydroxyl groups) and sorbitol (6 carbons with 6 hydroxyl groups) possess different numbers of hydroxyl groups and carbon chain lengths, which leads to distinct regioselectivity. Since the art teaches the structure a mixed composition comprising the mixture of n- nonanoic esters, it is the Examiners position that the composition would necessarily have less than 25% by weight, of free n-nonanoic acid, where the percentages by weight are based on the sum total of all n- nonanoic esters of xylitol, sorbitol and erythritol and n-nonanoic acid. With respect to claim 6, since the art teaches the structure a mixed composition comprising the mixture of n- nonanoic esters, it is the Examiners position that the composition would necessarily have 0.05% by weight to 40% by weight, of free xylitol, sorbitol and/or erythritol, where the percentages by weight are based on the sum total of all n-nonanoic esters of xylitol, sorbitol and erythritol and all xylitol, sorbitol and erythritol. With respect to claim 7, since the art teaches the structure a mixed composition comprising the mixture of n- nonanoic esters, it is the Examiners position that the composition would necessarily have 0.1% by weight to 60% by weight of at least one solvent. With respect to claim 16, since the art teaches the structure of a mixture of n-nonanoic esters of xylitol and sorbitol, it is the Examiners position that mixture of n-nonanoic esters would necessarily comprise mono-n-nonanoic ester, di-n-nonanoic ester, and tri-n-nonanoic ester. With respect to claim 17, since the art teaches the structure of a mixture of n-nonanoic esters of xylitol and sorbitol, it is the Examiners position that mixture of n-nonanoic esters would necessarily comprise an average level of esterification of 1.0 to 3. With respect to claim 18, since the art teaches the structure of a mixture of n-nonanoic esters of xylitol and sorbitol, it is the Examiners position that mixture of n-nonanoic esters would necessarily comprise an average level of esterification of 1.1 to 2.7. With respect to claim 19, since the art teaches the structure of a mixture of n-nonanoic esters of xylitol and sorbitol, it is the Examiners position that mixture of n-nonanoic esters would necessarily comprise an average level of esterification of 1.3 to 2.6. For the reasons stated herein, the teachings of ‘411 anticipate claims 1-7, 16-19. RESPONSE TO REMARKS: Beginning on p. 2 of Applicant’s remarks, Applicants in summary contends that the invention taught by ‘411 differs from the instant application because Component A is not disclosed or taught as either xylitol or sorbitol. Applicant contends that there is also no single embodiment or enabling disclosure in Denda of any mixture of specifically n-nonanoic esters, or n-nonanoic esters of even just erythritol. Applicant contends that if the polyol is erythritol, the present proviso of excluding an average level of esterification of greater than 3.2 is not met.. This argument is found to be not persuasive. Examiner contends that the product taught by ‘411 being comprised of an esterified product of component A and component B does not require the claimed ‘erythritol.’ Examiner contends that ‘411 teaches component A is comprised of Dipentaerythritol, erythritol, or sorbitan’ (page 2, para 2). Emphasis in the term ‘or.’ As such, Examiner contends that component A can be limited to include sorbitan (not include erythritol), of which would necessarily exclude n-nonanoic esters of erythritol with an average level of esterification of greater than 3.2 since, as recited in the instant application claim 1. Conclusion Status of Claims Claims 1-7, 16-19 are pending. Claims 8-15 stands withdrawn pursuant to 37 CFR 1.142(b). Claims 1-7, 16-19 are rejected. No claims are in condition for allowance. THIS ACTION IS MADE FINAL. Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. Any inquiry concerning this communication or earlier communications from the examiner should be directed to ERICA NICOLE JONES-FOSTER whose telephone number is (571)270-0360. The examiner can normally be reached mf 7:30a - 4:30p. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Manjunath Rao can be reached at 571-272-0939. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /ERICA NICOLE JONES-FOSTER/ Examiner, Art Unit 1656 /MANJUNATH N RAO/ Supervisory Patent Examiner, Art Unit 1656 (nr)
Read full office action

Prosecution Timeline

Dec 13, 2023
Application Filed
Jan 05, 2024
Response after Non-Final Action
Feb 05, 2026
Non-Final Rejection mailed — §102
May 05, 2026
Response Filed
Jul 10, 2026
Final Rejection mailed — §102 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12643927
ENGINEERED SPIDER SILK PROTEINS AND USES THEREOF
3y 9m to grant Granted Jun 02, 2026
Patent 12600761
METHODS AND COMPOSITIONS FOR PURIFICATION OF TRIMERIC FUSION PROTEINS
3y 1m to grant Granted Apr 14, 2026
Patent 12594308
METHODS OF PREPARING A POSTBIOTIC COMPOSITION
1y 6m to grant Granted Apr 07, 2026
Patent 12590291
METHOD OF INDUCING EXPRESSION OF CALCIUM CHANNEL AND/OR CALCIUM PUMP, AND APPARATUS THEREFOR
3y 11m to grant Granted Mar 31, 2026
Patent 12583886
SLIDING CLAMP-BASED AFFINITY PURIFICATION SYSTEMS, METHODS OF MAKING AND USE THEREOF
4y 9m to grant Granted Mar 24, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4
Expected OA Rounds
50%
Grant Probability
98%
With Interview (+47.5%)
3y 4m (~8m remaining)
Median Time to Grant
Moderate
PTA Risk
Based on 76 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month